References
- Albrechtsen O. K., Storm O., Claassen M. Fibrinolytic Activity In Some Human Body Fluids. Scand. J. clin. Lab. Invest. 1958; 10: 310
- Astrup T. The Biological Significance of Fibrinolysis. Lancet 1956; 2: 565
- Burstein M., Guinand A. Fibrinolysis in organism. Blood 1956; 11: 781
- Alexander B., Albrechtsen O. K. Estimation of the Plasminogen Activator and the Trypsin Inhibitor in Animal and Human Tissues. Scand. J. clin. Lab. Invest. 1957; 9: 233
- Blomstrand R., Nakayama F. Application of Neutron Activation Paper Chromatographic Analysis of Phospholipids in Clinical Investigation. Scand. J. clin. Lab. Invest. 1962; 14: 28
- Nakayama F., Nilsson I. M. Identification of Phospholipids in Human Thrombocytes and Erythrocytes. J. Lab. Clin. Med. 1962; 59: 771
- Borgström B. Investigation on Lipid Separation Methods. Separation of Phospholipids from Neutral Fat and Fatty Acids. Acta physiol. scand. 1952; 25: 101
- Dawson R. M. C. A Hydrolytic Procedure for the Identification and Estimation of Individual Phospholipids in Biological Samples. Biochem. J. 1960; 75: 45
- Fantl P., Nelson J. F. Coagulation in lymph. J. Physiol. 1953; 122: 33
- Fullerton H. W., Anastasopoulos G. Anticoagulant Therapy. Brit. med. J. 1949; 2: 1492
- Greig H. R. W. Inhibition of Fibrinolysis by Alimentary Lipaemia. Lancet 1956; 2: 16
- Hansen H. G., Aepinus K. Gerinnungsfaktoren in der Lymphe. Thrombos. Diathes. haemorrh. (Stuttg.) 1960; 4: 435
- Hougie C., Ayers F. Lipaemia and Fibrinolytic Potentiality. Lancet 1960; 1: 186
- Jacobsson K. I. Studies on the Determination of Fibrinogen in Human Blood Plasma II. Studies on the Trypsin and Plasmin Inhibitors in Human Blood Serum. Scand. J. clin. Lab. Invest. 1955; 7
- Langdell R. D., Bowersox L. W., Weaver R. A., Gibson W. S. Coagulation properties of canine thoracic - duct lymph. Amer. J. Physiol. 1960; 199: 626
- Linder E., Blomstrand R. Technic for Collection of Thoracic Duct Lymph of Man. Proc. Soc. exp. Biol. (N.Y.) 1958; 97: 653
- Nilsson I. M., Blombäck M., von Francken I. On an Inherited Autosomal Hemorrhagic Diathesis with Antihemophilic Globulin (AHG) Deficiency and Prolonged Bleeding Time. Acta med. scand. 1957; 159: 35
- Krook H., Sternby N.-H., Söderberg E., Söderström N. Severe Thrombotic Disease in a Young Man with Bone Marrow and Skeletal Changes and with a High Content of an Inhibitor in the Fibrinolytic System. Ibid. 1961; 169: 323
- Sjoerdsma A., Waldenström J. Antifibrinolytic Activity and Metabolism of σ -Aminocaproic Acid in Man. Lancet 1960; 1: 1322
- Skanse B., Gydell K. Fibrinolysis in Boeck's Sarcoid. Acta med. scand. 1957; 159: 463
- Nitzberg S. I., Peyman M. A., Goldstein R., Proger S. Studies of Blood Coagulation and Fibrinolysis in Patients with Idiopathic Hyperlipemia and Primary Hypercholesterolemia before and after a Fatty Meal. Circulation 1959; 19: 676
- Norman P. S. The plasmin system. II. Inhibition of plasmin by serum or plasma. J. exp. Med. 1958; 108: 53
- Mason M. F., Hawley G., Hill B. M. Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma. Ibid. 1958; 108: 633
- Nyman M. Serumhaptoglobin, Methodological and Clinical studies. Scand. J. clin. Lab. Invest. 1959; II
- O'Brien J. R. The similarity of the action of phosphatidyl ethanolamine and platelets in blood coagulation. J. clin. Path. 1956; 9: 47
- Burstein M., Guinand A. Phospholipids, Proteins and Platelet-Lipoid. Nature 1958; 181: 420
- Robinson D. S., Poole J. C. F. The similar effect of chylomicra and ethanolamine phosphatide on the generation of thrombin during coagulation. Quart. J. exp. Physiol. 1956; 41: 36
- Rybák M., Rejnek J. The Antiplasmin Effect of Plasma Fractions. Clin. chim. Acta 1959; 4: 364
- Troup S. B., Reed C. F. Platelet Thromboplastic Factor: Its Chemical Nature, In Vitro Activity, and the Identification of Similar Thromboplastic Substances in Red Blood Cells. J. clin. Invest. 1958; 37: 937
- Wallach D., Surgenor D., Walters D. Sixth International Congress of the International Society of Hematology. Boston 1956; 335